BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27296462)

  • 21. Deciphering the Breast Density Inform Law Movement: Implications for Practice.
    Raj SD; Fein-Zachary V; Slanetz PJ
    Semin Ultrasound CT MR; 2018 Feb; 39(1):16-24. PubMed ID: 29317035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Between-Race Differences in Supplemental Breast Cancer Screening Before and After Breast Density Notification Law.
    Manning M; Albrecht TL; O'Neill S; Purrington K
    J Am Coll Radiol; 2019 Jun; 16(6):797-803. PubMed ID: 30342908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic Breast Density and Breast Cancer Risk: Implications of the Breast Density Legislation for Health Care Practitioners.
    Green VL
    Clin Obstet Gynecol; 2016 Jun; 59(2):419-38. PubMed ID: 26992182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dense Breast Notification Laws: Impact on Downstream Imaging After Screening Mammography.
    Horný M; Cohen AB; Duszak R; Christiansen CL; Shwartz M; Burgess JF
    Med Care Res Rev; 2020 Apr; 77(2):143-154. PubMed ID: 29347864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of legislation mandating breast density notification - Review of the evidence.
    Houssami N; Lee CI
    Breast; 2018 Dec; 42():102-112. PubMed ID: 30236594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dense Breasts: What Do Our Patients Need to Be Told and Why?
    Throckmorton AD; Rhodes DJ; Hughes KS; Degnim AC; Dickson-Witmer D
    Ann Surg Oncol; 2016 Oct; 23(10):3119-27. PubMed ID: 27401446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supplemental Screening With Automated Breast Ultrasound in Women With Dense Breasts: Comparing Notification Methods and Screening Behaviors.
    Aripoli A; Fountain K; Winblad O; Gatewood J; Hill J; Wick JA; Inciardi M
    AJR Am J Roentgenol; 2018 Jan; 210(1):W22-W28. PubMed ID: 29045183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dense breasts: a review of reporting legislation and available supplemental screening options.
    Ho JM; Jafferjee N; Covarrubias GM; Ghesani M; Handler B
    AJR Am J Roentgenol; 2014 Aug; 203(2):449-56. PubMed ID: 25055284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the new density reporting laws: radiologist perceptions and actual behavior.
    Gur D; Klym AH; King JL; Bandos AI; Sumkin JH
    Acad Radiol; 2015 Jun; 22(6):679-83. PubMed ID: 25837723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Breast Imaging in Breast Cancer Screening and Problem Solving.
    Shermis RB; Redfern RE; Burns J; Kudrolli H
    Radiographics; 2017; 37(5):1309-1606. PubMed ID: 28898193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry.
    Richman I; Asch SM; Bendavid E; Bhattacharya J; Owens DK
    J Gen Intern Med; 2017 Jun; 32(6):603-609. PubMed ID: 27844260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge of Density and Screening Ultrasound.
    Moothathu NS; Philpotts LE; Busch SH; Gross CP; Staib LH; Hooley RJ
    Breast J; 2017 May; 23(3):323-332. PubMed ID: 27943500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dense breast legislation in the United States: state of the states.
    Dehkordy SF; Carlos RC
    J Am Coll Radiol; 2013 Dec; 10(12):899-902. PubMed ID: 24295937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography.
    Busch SH; Hoag JR; Aminawung JA; Xu X; Richman IB; Soulos PR; Kyanko KA; Gross CP
    Am J Public Health; 2019 May; 109(5):762-767. PubMed ID: 30896987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends of Supplemental Screening in Women With Dense Breasts.
    Choudhery S; Patel BK; Johnson M; Geske J; Fazzio RT; Lee C; Pruthi S
    J Am Coll Radiol; 2020 Aug; 17(8):990-998. PubMed ID: 32105645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of State Policies Impact Health Care Delivery: An Analysis of Mammographic Dense Breast Notification and Insurance Legislation.
    Horný M; Shwartz M; Duszak R; Christiansen CL; Cohen AB; Burgess JF
    Med Care; 2018 Sep; 56(9):798-804. PubMed ID: 30036236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital breast tomosynthesis utilization in the United States: a survey of physician members of the Society of Breast Imaging.
    Hardesty LA; Kreidler SM; Glueck DH
    J Am Coll Radiol; 2014 Jun; 11(6):594-9. PubMed ID: 24713501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the California Breast Density Law on Screening Breast MR Utilization, Provider Ordering Practices, and Patient Demographics.
    Ram S; Sarma N; López JE; Liu Y; Li CS; Aminololama-Shakeri S
    J Am Coll Radiol; 2018 Apr; 15(4):594-600. PubMed ID: 29622173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of Whole-Breast Screening Ultrasonography.
    Durand MA; Hooley RJ
    Radiol Clin North Am; 2017 May; 55(3):527-539. PubMed ID: 28411678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation.
    Price ER; Hargreaves J; Lipson JA; Sickles EA; Brenner RJ; Lindfors KK; Joe BN; Leung JW; Feig SA; Bassett LW; Ojeda-Fournier H; Daniel BL; Kurian AW; Love E; Ryan L; Walgenbach DD; Ikeda DM
    Radiology; 2013 Dec; 269(3):887-92. PubMed ID: 24023072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.